Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis

Thorax

Volumn 66, Issue 3, 2011, Pages 259-

  Nash, Edward F ^a   Whitmill, Richard ^a   Barker, Bethan ^a   Rashid, Rifat ^a   Whitehouse, Joanna L ^a   Honeybourne, David ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; OSELTAMIVIR;

ANTIBIOTIC THERAPY; BODY MASS; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HUMAN; INFLUENZA VIRUS A H1N1; LETTER; PANDEMIC; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWINE INFLUENZA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 79951910753     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.140822     Document Type: Letter

References (5)

1. Wat D, Gelder C, Hibbitts S, et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008;7:320-8.
2. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44.
3. Whitaker P, Etherington C, Denton M, et al. A/H1N1 and other viruses affecting cystic fibrosis. BMJ 2009;339:b3958.
4. France MW, Tai S, Masel PJ, et al. The month of July: an early experience with pandemic influenza (H1N1) in adults with cystic fibrosis. BMC Pulm Med 2010;10:8.
5. Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave, 2009. http://www.hpa.org.uk/web/ HPAwebFile/HPAweb-C/1258560552857.